Learn how to manage chronic inflammatory demyelinating polyradiculoneuropathy (CIDP) at work, including legal protections, ...
President and CEO Doug Love outlined the company’s late-stage pipeline and regulatory plans during a presentation at the Bank of America Healthcare Conference, highlighting upcoming data in geographic ...
There are many ways to create mental and physical separation from your work, including transition rituals, after-work routines, and mindfulness exercises. It can be easy to mentally carry your work ...
For people living with primary immunodeficiency, immunoglobulin replacement therapy is a cornerstone of treatment. These therapies help replace missing antibodies and reduce the risk of serious or ...
Good afternoon, everyone. I hope you're enjoying the first day of the conference and all the festivities. My name is Alex Buckley. I'm with the Healthcare Investment Banking Group, and it's my ...
Forbes contributors publish independent expert analyses and insights. Dr. Tracy Brower writes about joy, community and the future of work. There is a lot of hype about AI, including plenty of opinions ...
During a recent workshop, a senior executive said to me, “None of us knows how people will learn in this new era.” Lynda Gratton is a professor of management practice at London Business School. Her ...
Chronic inflammatory demyelinating polyneuropathy (CIDP) is thought to be an autoimmune condition. When you have CIDP, your immune system sees your nerves as foreign and attacks them. The attack ...
Intravenous immunoglobulin (IVIG) therapy involves infusing patients with naturally occurring IgG antibodies to treat autoimmune conditions. With origins dating back to the 1950s, IVIG is currently ...
Intravenous immunoglobulin (IVIG) therapy involves infusing patients with naturally occurring IgG antibodies to treat autoimmune conditions. With origins dating back to the 1950s, IVIG is currently ...
Efgartigimod demonstrated superior efficacy over IVIG in improving MG-ADL and QMG scores in myasthenia gravis patients. Patients treated with efgartigimod experienced faster symptom improvement and ...